BioMarin Pharmaceutical (BMRN) News Today $59.67 +2.85 (+5.02%) As of 04/14/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Renaissance Technologies LLC Buys 17,000 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Renaissance Technologies LLC lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 435,871 shares of the biotechnology company's stock after buying an additionApril 14 at 5:14 AM | marketbeat.comLegal & General Group Plc Has $56.59 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Legal & General Group Plc lowered its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 41.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 860,927 shares of the biotechnology company's stockApril 14 at 4:57 AM | marketbeat.comAPG Asset Management N.V. Buys 113,655 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)APG Asset Management N.V. grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 587.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 132,987 shares of the biotechnology company'sApril 13 at 5:56 AM | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 1-Year Low - Here's What HappenedBioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 12-Month Low - Should You Sell?April 12 at 5:16 AM | marketbeat.comResona Asset Management Co. Ltd. Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Resona Asset Management Co. Ltd. bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 73,480 shares of the biotechnology company's stock,April 11, 2025 | marketbeat.comAlliancebernstein L.P. Sells 22,055 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Alliancebernstein L.P. lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 7.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 257,385 shares of the biotechnology company's stock after selling 22,055 shares during the period.April 11, 2025 | marketbeat.com6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic VolatilityApril 11, 2025 | fool.comCritical Review: NeuroBo Pharmaceuticals (NASDAQ:NRBO) and BioMarin Pharmaceutical (NASDAQ:BMRN)April 11, 2025 | americanbankingnews.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by ExodusPoint Capital Management LPExodusPoint Capital Management LP reduced its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 36.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,817 shares of the biotechnologyApril 8, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Rhenman & Partners Asset Management ABRhenman & Partners Asset Management AB decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 31.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 250,623 shares of the biotechnology companApril 7, 2025 | marketbeat.comGeode Capital Management LLC Has $215.78 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Geode Capital Management LLC grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 0.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,288,778 shares of the biotechnology company'sApril 7, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Sets New 52-Week Low - Here's What HappenedBioMarin Pharmaceutical (NASDAQ:BMRN) Hits New 52-Week Low - What's Next?April 6, 2025 | marketbeat.comMotley Fool Asset Management LLC Reduces Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Motley Fool Asset Management LLC cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 91.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,312 shares of the biotechnology company's stock after selling 135,486April 6, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Schroder Investment Management GroupSchroder Investment Management Group cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 94.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 218,964 shares ofApril 5, 2025 | marketbeat.comClearbridge Investments LLC Sells 35,140 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Clearbridge Investments LLC decreased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 14.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 210,254 shares of the bioApril 4, 2025 | marketbeat.comAllstate Corp Takes $368,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Allstate Corp bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 5,594 shares of the biotechnology company's stock, valued at approximately $368,000. OtheApril 4, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Downgraded by StockNews.com to BuyStockNews.com lowered shares of BioMarin Pharmaceutical from a "strong-buy" rating to a "buy" rating in a research report on Tuesday.April 3, 2025 | marketbeat.comTruist Financial Reaffirms Their Buy Rating on BioMarin Pharmaceutical (BMRN)April 3, 2025 | markets.businessinsider.comBioMarin Pharmaceutical: Pegasus Success May Lead To Palynziq Label ExpansionApril 3, 2025 | seekingalpha.comGroupama Asset Managment Has $6.77 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Groupama Asset Managment increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 7.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 103,424 shares of the biotechnology company's stockApril 3, 2025 | marketbeat.comTrexquant Investment LP Trims Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Trexquant Investment LP lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 29.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 219,040 shares of the biotechnology companyApril 3, 2025 | marketbeat.comBioMarin: Phase 3 PEGASUS trial of Palynziq met primary endpointApril 3, 2025 | markets.businessinsider.comPictet Asset Management Holding SA Sells 634,916 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Pictet Asset Management Holding SA cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 69.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,700 shares ofApril 3, 2025 | marketbeat.comBioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent PatientsApril 2, 2025 | finance.yahoo.comBioMarin Pharmaceutical: Promising Growth Driven by Palynziq Success and Pipeline OpportunitiesApril 2, 2025 | tipranks.comIs BioMarin Pharmaceutical Inc. (BMRN) The Most Profitable Biotech Stock To Buy Right Now?April 2, 2025 | insidermonkey.comBioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with PhenylketonuriaApril 2, 2025 | prnewswire.comKnott David M Jr Decreases Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Knott David M Jr lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 82.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 5,800 shares of the biotechnology company's stock after selling 28,200 shares during the peApril 2, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Has $9.57 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 13.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 143,145 shApril 2, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Edmond DE Rothschild Holding S.A.Edmond DE Rothschild Holding S.A. raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 36.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 563,530 shares ofApril 1, 2025 | marketbeat.comNew Age Alpha Advisors LLC Buys Shares of 23,422 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)New Age Alpha Advisors LLC purchased a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 23,422 shares of the biotechnology companApril 1, 2025 | marketbeat.comNorges Bank Acquires New Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Norges Bank bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 3,569,831 shares of the biotechnology company's stock, valued at approximately $234,645,000. Norges BApril 1, 2025 | marketbeat.comKorea Investment CORP Purchases 131,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 362.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,903 shares of the biotechnology company's stock aftApril 1, 2025 | marketbeat.comAllianz SE Buys Shares of 46,830 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Allianz SE bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 46,830 shares of the biotechnology company's stock, valued at approximately $3,065,000. SeverMarch 31, 2025 | marketbeat.comNomura Asset Management Co. Ltd. Lowers Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Nomura Asset Management Co. Ltd. cut its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 15.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 412,299 shares of the biotechnolMarch 31, 2025 | marketbeat.comMitsubishi UFJ Trust & Banking Corp Lowers Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Mitsubishi UFJ Trust & Banking Corp lowered its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 26.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 154,835 shares of the biMarch 31, 2025 | marketbeat.comPrudential Financial Inc. Boosts Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Prudential Financial Inc. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 131.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 144,082 shares of the biotechnology company's stock after purchasing an additional 81,887 shares durMarch 31, 2025 | marketbeat.com7 Most Profitable Biotech Stocks To Buy Right NowMarch 31, 2025 | insidermonkey.comWINTON GROUP Ltd Has $1.10 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)WINTON GROUP Ltd cut its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 21.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,674 shares of the biotechnology company's stock aMarch 30, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Consensus Recommendation of "Moderate Buy" from AnalystsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) has received a consensus rating of "Moderate Buy" from the twenty-four ratings firms that are covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold rating and seventeen have given a bMarch 30, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Holdings Lowered by DnB Asset Management ASDnB Asset Management AS cut its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 7.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 993,170 shares of the biotechnology company's stock aMarch 29, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Holdings Increased by Vanguard Group Inc.Vanguard Group Inc. boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,372,185 shares of the biotechnology company's stock after purchasMarch 29, 2025 | marketbeat.comBioMarin Pharmaceutical Target of Unusually Large Options Trading (NASDAQ:BMRN)BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors purchased 5,111 call options on the company. This represents an increase of approximately 273% compared to the average volume of 1,372 call options.March 28, 2025 | marketbeat.comHowe & Rusling Inc. Decreases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Howe & Rusling Inc. decreased its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 20.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,355 shares of the biotechnology companMarch 28, 2025 | marketbeat.comMotley Fool Wealth Management LLC Has $22.73 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Motley Fool Wealth Management LLC reduced its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 18.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 347,728 shares of the biotechnology company's stock after selling 76,869 shares during theMarch 27, 2025 | marketbeat.com5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq CorrectionMarch 27, 2025 | fool.comCorebridge Financial Inc. Sells 9,486 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Corebridge Financial Inc. reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 215,638 shares of the biotechnology company's stock aMarch 27, 2025 | marketbeat.com2 Reasons to Like BMRN (and 1 Not So Much)March 26, 2025 | finance.yahoo.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Fox Run Management L.L.C.Fox Run Management L.L.C. lessened its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 42.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 8,216 shares of the biotechnology company's stock after selling 6,150 shares during the period. FoxMarch 26, 2025 | marketbeat.comKLP Kapitalforvaltning AS Takes $4.39 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)KLP Kapitalforvaltning AS bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 66,737 shares of the biotechnology company's stocMarch 26, 2025 | marketbeat.com Remove Ads Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼0.950.83▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼1011▲BMRN Articles Average Week Remove Ads Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today BIIB News Today UTHR News Today INCY News Today EXEL News Today NBIX News Today EXAS News Today HALO News Today MDGL News Today RGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
